98 related articles for article (PubMed ID: 11876442)
41. In-vitro and in-vivo antitumour activity of physalins B and D from Physalis angulata.
Magalhães HI; Veras ML; Torres MR; Alves AP; Pessoa OD; Silveira ER; Costa-Lotufo LV; de Moraes MO; Pessoa C
J Pharm Pharmacol; 2006 Feb; 58(2):235-41. PubMed ID: 16451752
[TBL] [Abstract][Full Text] [Related]
42. Synthesis of new amonafide analogues via coupling reaction and their cytotoxic evaluation and DNA-binding studies.
Xie L; Xu Y; Wang F; Liu J; Qian X; Cui J
Bioorg Med Chem; 2009 Jan; 17(2):804-10. PubMed ID: 19070496
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
[TBL] [Abstract][Full Text] [Related]
44. Enantioselective cytotoxic activity of bromine-substituted analogues of ifosfamide. A microsomal implication.
Hładoń B; Sloderbach A; Laskowska H
Pol J Pharmacol; 1997; 49(2-3):127-36. PubMed ID: 9437759
[TBL] [Abstract][Full Text] [Related]
45. Micronucleus-inducing and antitumor activity of three newly synthesized bridged nitrogen atom-containing pyrimidines.
Nersesyan A; Muradyan R; Arsenyan F; Danagulyan G
J BUON; 2006; 11(3):329-34. PubMed ID: 17309158
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
Karki SS; Thota S; Darj SY; Balzarini J; De Clercq E
Bioorg Med Chem; 2007 Nov; 15(21):6632-41. PubMed ID: 17765549
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, antitubercular and anticancer activities of substituted furyl-quinazolin-3(4H)-ones.
Raghavendra NM; Thampi P; Gurubasavarajaswamy PM; Sriram D
Arch Pharm (Weinheim); 2007 Dec; 340(12):635-41. PubMed ID: 17994604
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents.
Ishar MP; Singh G; Singh S; Sreenivasan KK; Singh G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1366-70. PubMed ID: 16332438
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs.
Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G
Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and cytotoxic evaluation of some cribrostatin-ecteinascidin analogues.
Wright BJ; Chan C; Danishefsky SJ
J Nat Prod; 2008 Mar; 71(3):409-14. PubMed ID: 18278868
[TBL] [Abstract][Full Text] [Related]
51. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
Yin H; Xu Y; Qian X; Li Y; Liu J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
[TBL] [Abstract][Full Text] [Related]
52. Spin-labeled 1-alkyl-1-nitrosourea synergists of antitumor antibiotics.
Gadjeva V; Koldamova R
Anticancer Drug Des; 2001; 16(4-5):247-53. PubMed ID: 12049483
[TBL] [Abstract][Full Text] [Related]
53. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
Raghavendra NM; Gurubasavarajaswamy PM; Nagaranavile KS; Parameshwaran T
Arch Pharm Res; 2009 Mar; 32(3):431-6. PubMed ID: 19387588
[TBL] [Abstract][Full Text] [Related]
54. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
55. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
56. Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation.
Cemazar M; Pipan Z; Grabner S; Bukovec N; Sersa G
Anticancer Res; 2006; 26(3A):1997-2002. PubMed ID: 16827135
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of novel chloroethylaminoanthraquinones with potent cytotoxic activity against cisplatin-resistant tumor cells.
Pors K; Paniwnyk Z; Ruparelia KC; Teesdale-Spittle PH; Hartley JA; Kelland LR; Patterson LH
J Med Chem; 2004 Mar; 47(7):1856-9. PubMed ID: 15027879
[TBL] [Abstract][Full Text] [Related]
58. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
59. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores.
Tercel M; Stribbling SM; Sheppard H; Siim BG; Wu K; Pullen SM; Botting KJ; Wilson WR; Denny WA
J Med Chem; 2003 May; 46(11):2132-51. PubMed ID: 12747786
[TBL] [Abstract][Full Text] [Related]
60. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase.
Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA
J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]